Valneva SE VALN
NASDAQ VALN
$5.90 -0.28 (-4.61%)
At close: Oct 1, 2026 · 4:00 PM EDT

Valneva SE (VALN) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Valneva SE's Liabilities and Shareholders Equity came in at $451.32 million for Q2 2026, down 15.6% from $534.99 million a year earlier but up 3.6% from the prior quarter.

Analysis

Valneva SE (VALN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Valneva SE's Liabilities and Shareholders Equity was $450.61 million, down 15.7% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $534.33 million in FY2024 (+7.9%), $495 million in FY2023 (-21.9%), $633.92 million in FY2022 (-34.5%) and $967.25 million in FY2021 (+88.6%).
  • The five-year range for quarterly Liabilities and Shareholders Equity is $435.53 million (Q1 2026) to $935.03 million (Q4 2021).
  • Year-over-year, Liabilities and Shareholders Equity has declined for four consecutive quarters, with an average decline of 5.4% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 74.6%), and the weakest in Q4 2022 (a decline of 32.2%).
  • Business Quant data shows VALN's Liabilities and Shareholders Equity at $435.53 million (Q1 2026), $464.26 million (Q4 2025) and $524 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Valneva SE 536.24 Mn -23.65 Mn 1.86 Mn 451.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 451.32 Mn
Mar 31, 2026 435.53 Mn
Dec 31, 2025 464.26 Mn
Sep 30, 2025 524.00 Mn
Jun 30, 2025 534.99 Mn
Mar 31, 2025 507.26 Mn
Dec 31, 2024 534.33 Mn
Sep 30, 2024 567.36 Mn
Jun 30, 2024 502.44 Mn
Mar 31, 2024 546.25 Mn
Dec 31, 2023 495.00 Mn
Sep 30, 2023 566.65 Mn
Jun 30, 2023 590.82 Mn
Mar 31, 2023 633.27 Mn
Dec 31, 2022 633.92 Mn
Sep 30, 2022 703.86 Mn
Jun 30, 2022 773.73 Mn
Mar 31, 2022 872.85 Mn
Dec 31, 2021 935.03 Mn
Dec 31, 2020 535.53 Mn
API Access

Valneva SE Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VALN&period=max&api_key=YOUR_API_KEY